@article{Kramer2017progr-39148,
  year={2017},
  doi={10.1371/journal.pone.0174858},
  title={Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?},
  number={4},
  volume={12},
  journal={PLOS ONE},
  author={Krämer, Julia and Tenberge, Jan-Gerd and Kleiter, Ingo and Gaissmaier, Wolfgang and Ruck, Tobias and Heesen, Christoph and Meuth, Sven G.},
  note={Article Number: e0174858}
}

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39148">
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/39148/1/Kraemer_0-408546.pdf"/>
    <dc:creator>Meuth, Sven G.</dc:creator>
    <dc:contributor>Kleiter, Ingo</dc:contributor>
    <dc:contributor>Heesen, Christoph</dc:contributor>
    <dcterms:abstract xml:lang="eng">Progressive multifocal leukoencephalopathy (PML) is one of the major risks of natalizumab therapy. Despite introduction of the currently employed PML risk stratification algorithm, the incidence of natalizumab-associated PML cases is not decreasing.</dcterms:abstract>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:creator>Tenberge, Jan-Gerd</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-07T09:26:48Z</dc:date>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/39148"/>
    <dc:contributor>Gaissmaier, Wolfgang</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/39148/1/Kraemer_0-408546.pdf"/>
    <dc:contributor>Krämer, Julia</dc:contributor>
    <dcterms:issued>2017</dcterms:issued>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-07T09:26:48Z</dcterms:available>
    <dc:creator>Kleiter, Ingo</dc:creator>
    <dc:creator>Gaissmaier, Wolfgang</dc:creator>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dc:contributor>Tenberge, Jan-Gerd</dc:contributor>
    <dc:creator>Heesen, Christoph</dc:creator>
    <dc:creator>Krämer, Julia</dc:creator>
    <dcterms:title>Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?</dcterms:title>
    <dc:creator>Ruck, Tobias</dc:creator>
    <dc:contributor>Ruck, Tobias</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:contributor>Meuth, Sven G.</dc:contributor>
  </rdf:Description>
</rdf:RDF>